Literature DB >> 15542733

Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.

Hideaki Kobayashi1, Soichiro Ide, Junko Hasegawa, Hiroshi Ujike, Yoshimoto Sekine, Norio Ozaki, Toshiya Inada, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Masaomi Iyo, Hao-Wei Shen, Kazutaka Ikeda, Ichiro Sora.   

Abstract

Methamphetamine (MAP) dissipates proton gradients across the membranes of synaptic vesicles, enhances cytoplasmic dopamine (DA) concentrations, and causes calcium-independent, nonvesicular DA release into synapses. MAP is taken into the cytosol by the dopamine transporter (DAT) on the synaptic terminals of DA neurons, and endogenous DA is concurrently released through the transporter by carrier exchange mechanisms, resulting in a robust increase in DA concentration in the synaptic clefts. The enhanced DA release through DAT by MAP is the main mechanism for the reinforcing effects of MAP. The complexes of alpha-synuclein and DAT facilitate membrane clustering of the DAT, thereby accelerating DA uptake in vitro. alpha-Synuclein has been shown to be overexpressed in the midbrain DA neurons of chronic cocaine abusers. The present study was performed to study the association between the alpha-synuclein gene polymorphisms and MAP psychosis/dependence in Japanese population. Since the T10A7 polymorphic site at the 5' end of the noncoding exon 1' in the alpha-synuclein gene is highly polymorphic, we analyzed the noncoding exon 1' and intron 1, including this polymorphic site by sequencing. We confirmed four single nucleotide polymorphisms (SNPs) within 1.38 kbp of the T10A7 polymorphic site. No significant difference was found in genotype or allele frequencies in the T10A7 polymorphic site between MAP psychotic/dependent and control subjects. We found significant association between three SNPs in the vicinity of this polymorphic site in intron 1 and MAP psychosis/dependence in female subjects, but not in males. These results suggest an association of the alpha-synuclein gene polymorphisms with MAP psychosis/dependence in our female subjects. Further analyses are necessary to clarify the gender difference, by using a larger sample size and/or different ethnic groups, as well as functional variations in the alpha-synuclein gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542733     DOI: 10.1196/annals.1316.040

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 3.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

Review 4.  Genetic factors modulating the response to stimulant drugs in humans.

Authors:  Amy B Hart; Harriet de Wit; Abraham A Palmer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 5.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

6.  Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood.

Authors:  Chad A Bousman; Gursharan Chana; Stephen J Glatt; Sharon D Chandler; Todd May; James Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-05       Impact factor: 3.568

7.  Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes.

Authors:  Shabnam Nohesara; Mohammad Ghadirivasfi; Mahmood Barati; Mohammad-Reza Ghasemzadeh; Samira Narimani; Zohreh Mousavi-Behbahani; Mohammadtaghi Joghataei; Mansoureh Soleimani; Mozhgan Taban; Soraya Mehrabi; Sam Thiagalingam; Hamid Mostafavi Abdolmaleky
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-18       Impact factor: 3.568

Review 8.  Biological treatments for amfetamine dependence : recent progress.

Authors:  Kevin P Hill; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers.

Authors:  Deborah C Mash; Nikhil Adi; Linda Duque; John Pablo; Mahendra Kumar; Frank R Ervin
Journal:  Drug Alcohol Depend       Date:  2007-12-04       Impact factor: 4.492

Review 10.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.